Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.
Jili DengLan MiXiaopei WangJun ZhuChen ZhangYuqin SongPublished in: Hematology (Amsterdam, Netherlands) (2022)
: This is the first study to explore the prognostic risk factors and relapse factorsof PB-DLBCL in a relatively large Chinese PBL cohort. Local breast and CNS recurrence after standard R-CHOP treatment were the main issues we are facing now.